Alfred S. L. Cheng
Institute of Digestive Disease
The Chinese University of Hong Kong
Hong Kong SAR
China
Name/email consistency: high
- EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cheng, A.S., Lau, S.S., Chen, Y., Kondo, Y., Li, M.S., Feng, H., Ching, A.K., Cheung, K.F., Wong, H.K., Tong, J.H., Jin, H., Choy, K.W., Yu, J., To, K.F., Wong, N., Huang, T.H., Sung, J.J. Cancer Res. (2011)
- Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. Cheng, A.S., Chan, H.L., To, K.F., Leung, W.K., Chan, K.K., Liew, C.T., Sung, J.J. Int. J. Oncol. (2004)
- Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng, A.S., Chan, H.L., Leung, W.K., Wong, N., Johnson, P.J., Sung, J.J. Int. J. Oncol. (2003)